Mr. Speaker, I listened attentively to the previous two interventions and to the questions and answers associated with them. I am more relieved now that we are back in focus. I thought initially, without being sarcastic, that the issue was no longer one as indicated by the motion but rather one of wrangling about parliamentary procedures.
It is important that on an issue like the one before us today we think in long term vision, we look at the errors of the past, we try to reconstruct and go forward.
In dealing with the complex issue of assistance for those Canadians infected with hepatitis C during a time when the blood system could have responded differently but did not, it is important to point out that all Canada's governments, the territorial and provincial governments of all partisans stripes as well as the federal government, have taken decisive actions to ensure that such tragic events do not occur again. It is a point that should be kept in mind as we debate the issue over the course of this day.
It is also important to keep in mind that public faith and confidence in blood safety have suffered as a result of past events. We should not exasperate that. Canadians need reassurance that the blood supply, the blood system today, is safe and effective in Canada as it is in any other country. That is what I would like to speak about today, the progress made by governments to resolve the issue of confidence in blood safety.
I am pleased to inform the House on how governments, this government in particular, are working together with partners to build a new, safe and integrated blood system. In speaking about that progress, I will be speaking about partnership. Restoring confidence in blood safety and building a better blood system hinges on bringing many partners together to achieve a common goal. Partners and stakeholders are essential to any effective national system. This spirit is our guide in building a better blood system where all stakeholders can have confidence that they play a role and have a voice that will be heard.
In Canada, as elsewhere, governments, consumers, those harmed, their families, specialists, scientists and others have all been working to ensure safer blood supplies and better systems of delivery.
In Canada we have made a great deal of progress in designing an appropriate structure for our new blood system. Working closely together with our provincial and territorial partners who own and operate the blood system as a part of their health care systems, we are well on track with transition plans.
A transition bureau has already been appointed. The bureau is working hard to ensure that the new Canadian blood services is up and operating as soon as possible with a target date for September 1998. Of course many operational details still have to be worked out. However, all those involved are committed to making the transition as smooth, as seamless and as safe as possible.
Canada's new blood system is a product of consensus and partnership among all key stakeholders. This is only right because the blood system belongs to each one of us.
By continuing to work together partners and stakeholders will achieve a new system in which we can all take pride. This is not just a technical or management exercise. Rebuilding confidence means earning respect and the good faith of blood donors, consumers, patients and all our citizens.
Mr. Justice Horace Krever's commission provided a clear assessment for Canadians about what went wrong in the 1980s and how we can ensure that it never happens again. Justice Krever set a path that governments and stakeholders are following. The way he has shown was drawn from what he heard during the extensive hearings of the commission and his careful deliberations on the events of the past.
One way we can show we have learned from the past is by building a system with all the feasible safeguards to ensure the past does not happen again.
Throughout the course of public hearings of the commission consumers, transfusion medicine specialists and management experts identified many deficiencies in the old blood system. They identified flaws as a lack of systematic, co-ordinated and rapid response in the face of emerging safety risks. They saw a lack of accountabilities for safety and governance. They saw rigid financing arrangements that did not reflect the focus on priorities of safety. They observed a fragmentation in blood science and research and development. Governments saw all this as well.
The Government of Canada took a lead role in bringing provinces and territories together to discuss ways to solve these problems. We asked consumers and scientists to join in the discussion. We consulted, we listened and we considered options.
Last September at a meeting in Fredericton, Canada's health ministers built on the substantial progress that had already been made and made a decisive step forward in the creation of a new, single agency to manage Canada's blood system.
The new Canadian blood services moved a step closer to becoming fully operational by September 1998. That agency will be responsible for managing all aspects of an accountable, fully integrated blood system. It is based on four key principles that government set out for the new blood system in 1996, principles which partners and stakeholders endorsed with enthusiasm.
First, the safety of the blood supply is of paramount importance if we want to earn the confidence of Canadians.
Second, a fully integrated approach is essential if we are to have a clear and coherent system in which all participants work effectively and co-operatively.
Third, accountabilities must be clear so that people inside the system and outside it know who is responsible for action.
Fourth, the system must be transparent because it needs to operate in full view with its windows and doors wide open for public inspection. All those involved in the planning of the new blood system will examine his advice carefully.
Let me say a word about Quebec. So far, Quebec has decided not to be a part of the blood system plans. Quebec is pursuing its own efforts to incorporate the blood system operations in its health care system.
Ways to collaborate with the Canadian blood system and the new blood system can be discussed. Of course blood and blood products used by patients in Quebec have to comply with federal regulations for safety and efficacy, the same as anywhere else in Canada.
What role does the federal government play in the new blood system? The role is quite different from that of the provinces and the territories. The provinces and territories are responsible and accountable for the national blood program. They set funding, broad health policy objectives and ensure the overall integrity of the system. The Government of Canada is supporting them as they manage the transition to the new system. This is very much in keeping and consistent with our role in pursuing better ways to improve and enhance the health of all Canadians.
For that reason, the government agreed to provide a grant of up to $81 million to support the start-up of the new system. Will the Government of Canada play other roles now and when the system is up and running? Of course.
Blood safety is a priority for the government and the government will continue to work to make blood as safe as it can be.